The data in Table 6 and Table 7, Figures S2 and S3 show that combining SDF-1/54 with any of the above ARV drugs produced strong synergistic and complementary effects against infection by HIV-1 IIIB and NL4-3 in TZM-bl respectively. This evidence concerns the gene CXCL12 and infection.